| What's Your Scleroderma Action Plan? |
|
|
|
| Friday, 31 August 2012 16:58 |
|
Today, we would like to encourage you ultimately have Faith and never lose hope. Faith and hope though, are meaningless without action. If you have not done so as yet, develop a long-term plan for dealing with your Scleroderma. With time and effort, a well formulated plan can help you understand and monitor your progress and quality of life. Here’s a simple, yet effective framework for getting your plan together: Define, Discuss, and Determine! Define: As with most other plans, it is important to first develop a thorough understanding of your current condition. Start with what type of Scleroderma you have, along with its associated symptoms, complications, and more. Research and collate what you can. Our own website and many others can help tremendously in this regard. Discuss: Next, it would be important to determine what your options are. They should be based on what your current resources (financial, physical, human, or otherwise), capabilities, strengths, and weaknesses are. Talk to your doctor about available treatments and possible courses of actions. Feel free to talk to other Scleroderma patients, as many have tried different techniques and strategies for treating, coping with, and managing their Scleroderma. Determine: With an in-depth understanding of your condition and assembling what your available options are, decide upon and determine a plan of action for managing your Scleroderma that is uniquely suited and tailored to you. Your plan should include a long-term goal and a number of contributing objectives. For instance, “I aim to live a full and healthy life, despite my Scleroderma”. Your objectives might then include;
It should also include your desired course of action, and what you would do to ensure that you’ve successfully completed those actions, thereby measuring your success and ability to execute on your plan. What’s Next? Well, with your plan in hand. The only thing left to do is execute! Here are a couple tips for doing so.
|
More articles :
» UC Davis Researchers Win Prestigious NIH Awards
The National Institutes of Health on Tuesday named three UC Davis researchers recipients of highly competitive awards designed to encourage innovative, high-risk research and accelerate the translation of science into improved health.Reflecting the...
» New Formulation of PAH Medication Is Now Available
Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, is now commercially available, according to the drug's maker, Actelion Pharmaceuticals US, Inc., of South San Francisco, Calif.The product is...
» ArGentis Seeks More Funding After Obtaining Patent for ARG201 Therapy
ArGentis Pharmaceuticals LLC has received a patent for its scleroderma therapy while finalizing plans for a Phase IIb trial for the treatment known as ARG201.The patent comes nearly two years after it was developed by University of Tennessee Health...
» Moves Toward Personalized Medicine for Scleroderma
researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study , an autoimmune disease for which there currently is no...
» New Understanding of Skin Hardening Syndromes Found
New details about the underlying mechanisms of skin hardening syndromes, morphea, have been discovered by researchers from (BUSM). Morphea, also known as localized scleroderma, is a disorder characterized by leading to thickening of the dermis,...
» Ryan Roy Racing to Raise Awareness of Scleroderma
Ryan Roy, of Bellingham, Wash., only has been doing triathlons for two years. In 2010, he completed three races at sprint and Olympic distances. For 2011, in addition to competing in sprint and Olympic triathlons, and his first half marathon in...


